Pacific Biomarkers Inc. Awarded Nine Contracts in Early 2011 for Studies in Immunogenicity, Diabetes and Other Areas
Pacific Biomarkers, Inc. (PBI) (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, has been awarded by one sponsor, nine contracts in early 2011 with a total value of approximately $920,000. The nine contracts are in the areas... - April 29, 2011
Pacific Biomarkers CSO Elizabeth T. Leary Co-Authors Paper in March Issue of Clinical Chemistry
Article Explores the Contribution of Assay Methodologies in Risk Classification for Cardiovascular Disease - March 11, 2011
Pacific Biomarkers’ Dr. Amar A. Sethi Recognized by R&D Directions as One of Nine “Most Notable People in R&D”
Vice President of R&D Singled Out For Work In Seeking Clues to Heart-Disease Risk - March 03, 2011
Pacific Biomarkers Names Sheri’ DuMond as Its New Director of Business Development
Pacific Biomarkers, Inc. (PBI) (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, has promoted Sheri’ DuMond to Director of Business Development following her role as Senior Associate Director of Business Development at... - February 04, 2011
Pacific Biomarkers, Inc. Announces Awards of Major Research Contracts
Pacific Biomarkers, Inc. (OTCBB: PBMC, “PBI”), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, announced today that it has been awarded two major research contracts with two multinational pharmaceutical companies (the... - January 13, 2011